相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Continued treatment with secukinumab is associated with high retention or regain of response
M. Augustin et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study
Andrea Chiricozzi et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2020)
Long-term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease
K. Reich et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study
M. Papini et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Redefining the therapeutic objective in psoriatic patients candidates for biological therapy
G. Carretero et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2018)
Efficacy and safety of secukinumab in treating moderate to severe plaque psoriasis in two real-world Canadian dermatology clinics: a multicenter retrospective study
J. R. Georgakopoulos et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study
A. Costanzo et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation
Marco Galluzzo et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study
Jorge R. Georgakopoulos et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5years of treatment (SCULPTURE Extension Study)
R. Bissonnette et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Obesity and response to anti-tumor necrosis factor-alpha agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis
Siddharth Singh et al.
PLOS ONE (2018)
Epidemiology of Psoriasis and Psoriatic Arthritis in Italy-a Systematic Review
Francesca Prignano et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
Andrew Blauvelt et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumab
J. Bagel et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
Diamant Thaci et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Iain B. McInnes et al.
LANCET (2015)
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials
Richard G. B. Langley et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2015)
PASI90 response: the new standard in therapeutic efficacy for psoriasis
L. Puig
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Impact of obesity on the efficacy of ustekinumab in Japanese patients with psoriasis: a retrospective cohort study of 111 patients
Koichi Yanaba et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
Obesity in autoimmune diseases: Not a passive bystander
Mathilde Versini et al.
AUTOIMMUNITY REVIEWS (2014)
Biologic fatigue in psoriasis
Ethan C. Levin et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2014)
Interleukin 17A: Toward a new understanding of psoriasis pathogenesis
Charles W. Lynde et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Research gaps in psoriasis: Opportunities for future studies
Caitriona Ryan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Secukinumab in Plaque Psoriasis - Results of Two Phase 3 Trials
Richard G. Langley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Relationships between adipose tissue and psoriasis, with or without arthritis
Eric Toussirot et al.
FRONTIERS IN IMMUNOLOGY (2014)
Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence
Rosa Parisi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Obesity, waist circumference, weight change and the risk of psoriasis in US women
S. Kumar et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL
Kenneth Gordon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Nail psoriasis as a severity indicator: results from the PsoReal study
Marc A. Radtke et al.
PATIENT-RELATED OUTCOME MEASURES (2011)
Obesity, waist circumference, weight change, and the risk of psoriasis in women - Nurses' health study II
Arathi R. Setty et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis
Stephen Tyring et al.
ARCHIVES OF DERMATOLOGY (2007)
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
K Reich et al.
LANCET (2005)
Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: Implications for clinical practice
AA Pettey et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
分享论文
